|
Type 2 diabetes
Citations 81-90 of 286 total displayed.
|
Past content
(since Dec 2000):
|
- Editorial Commentary
Is Dipeptidylpeptidase IV the Missing Link in Angiotensin-Converting Enzyme Inhibitor–Induced Angioedema?
- Eric Grouzmann and Thierry Buclin
Hypertension published November 19, 2007, doi:10.1161/HYPERTENSIONAHA.107.101329
[Abstract]
- Editorials
Adiponectin, Cardiovascular Function, and Hypertension
- Zhao V. Wang and Philipp E. Scherer
Hypertension published November 12, 2007, doi:10.1161/HYPERTENSIONAHA.107.099424
[Abstract]
- Editorial Commentaries
Left Ventricular Hypertrophy Reversal and Prevention of Diabetes: Two Birds With One Stone?
- Giuseppe Schillaci, Matteo Pirro, and Elmo Mannarino
Hypertension 2007;50:851-853; published online before print as doi:10.1161/HYPERTENSIONAHA.107.099747
[Full text]
- Original Articles
In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study
- Peter M. Okin, Richard B. Devereux, Katherine E. Harris, Sverker Jern, Sverre E. Kjeldsen, Lars H. Lindholm, Björn Dahlöf for the LIFE Study Investigators
Hypertension 2007;50:984-990; published online before print as doi:10.1161/HYPERTENSIONAHA.107.096818
[Abstract]
[Full text]
- Scientific Contributions
Amelioration of Cognitive Impairment in the Type-2 Diabetic Mouse by the Angiotensin II Type-1 Receptor Blocker Candesartan
- Kana Tsukuda, Masaki Mogi, Jian-Mei Li, Jun Iwanami, Li-Juan Min, Akiko Sakata, Teppei Fujita, Masaru Iwai, and Masatsugu Horiuchi
Hypertension published October 29, 2007, doi:10.1161/HYPERTENSIONAHA.107.099374
[Abstract]
- XVIIth Scientific Meeting of the Inter-American Society of Hypertension
Aldosterone Suppresses Insulin Signaling Via the Downregulation of Insulin Receptor Substrate-1 in Vascular Smooth Muscle Cells
- Hirofumi Hitomi, Hideyasu Kiyomoto, Akira Nishiyama, Taiga Hara, Kumiko Moriwaki, Kumiko Kaifu, Genei Ihara, Yoshiko Fujita, Toyomu Ugawa, and Masakazu Kohno
Hypertension 2007;50:750-755; published online before print as doi:10.1161/HYPERTENSIONAHA.107.093955
[Abstract]
[Full text]
- Scientific Contributions
In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients. The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study
- Peter M. Okin, Richard B. Devereux, Katherine E. Harris, Sverker Jern, Sverre E. Kjeldsen, Lars H. Lindholm, Björn Dahlöf LIFE Study Investigators
Hypertension published September 24, 2007, doi:10.1161/HYPERTENSIONAHA.107.096818
[Abstract]
- Editorial Commentary
Left Ventricular Hypertrophy Reversal and Prevention of Diabetes. Two Birds With One Stone?
- Giuseppe Schillaci, Matteo Pirro, and Elmo Mannarino
Hypertension published September 24, 2007, doi:10.1161/HYPERTENSIONAHA.107.099747
[Abstract]
- Editorial Commentaries
New-Onset Diabetes, Antihypertensive Treatment, and Outcome
- Paolo Verdecchia, Fabio Angeli, and Gianpaolo Reboldi
Hypertension 2007;50:459-460; published online before print as doi:10.1161/HYPERTENSIONAHA.107.096966
[Full text]
- Original Articles
Impact of New-Onset Diabetes Mellitus on Cardiac Outcomes in the Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) Trial Population
- Tonje A. Aksnes, Sverre E. Kjeldsen, Morten Rostrup, Per Omvik, Tsushung A. Hua, and Stevo Julius
Hypertension 2007;50:467-473; published online before print as doi:10.1161/HYPERTENSIONAHA.106.085654
[Abstract]
[Full text]
|
|
